NeuroPAS Global  -  The Company Behind The NP3 Solution

NeuroPAS Global provides enhanced pain assessment services through its unique NeuroPhysiologic Pain Profile, known as the NP3. The NP3 provides scientifically based medical analysis which brings added clarity to those involved in the diagnosis and treatment of chronic pain, as it accurately identifies and separates the complex elements in a patient's chronic pain experience. It identifies the multi-factorial causes of pain, aiding clinicians in providing the best care for their patients.

Dr. David B. Ross, creator of the NP3, is the guiding light in the Company’s focus on improving healthcare through use of the innovative NP3 neuro-medical technology. Dr. Ross graduated Johns Hopkins University and University of Miami before completing his post-doctoral studies in neurology at Harvard. He is a Board Certified member of the American Academy of Psychiatry and Neurology.

NeuroPAS Global is dedicated to improving healthcare, and reducing the administrative and financial burden of pain management on healthcare providers. By providing its new scientific approach to pain assessment, NeuroPAS Global offers a non-invasive pain assessment tool, the NP3, that identifies the true sources of patients’ pain symptoms. The cause of a patient’s pain can then be more appropriately managed, avoiding unnecessary surgeries, diagnostic tests and medications. This allows physicians, clinics, and pain management specialists to more accurately diagnose and treat pain symptoms, while improving patient recovery and satisfaction.

NeuroPAS Global LLC, 4302 W Broward Blvd - Suite 800, Plantation, FL 33317 USA |
Phone: 1-888-472-3188   |  Fax: 1-954-587-4018   |    Email: info@neuropasglobal.com